NR nicotinamide riboside Niagen
Selected indexed studies
- NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health. (Curr Nutr Rep, 2023) [PMID:37273100]
- Nicotinamide riboside and nicotinamide mononucleotide facilitate NAD(+) synthesis via enterohepatic circulation. (Sci Adv, 2025) [PMID:40117359]
- The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease. (Cell Metab, 2022) [PMID:35235774]
_Worker-drafted node — pending editorial review._
Connections
NR nicotinamide riboside Niagen helps
NR nicotinamide riboside Niagen protects against
Sources
- Regulation of and challenges in targeting NAD(+) metabolism. (2024) pubmed
- NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health. (2023) pubmed
- The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease. (2022) pubmed
- Nicotinamide riboside attenuates myocardial ischemia-reperfusion injury via regulating SIRT3/SOD2 signaling pathway. (2024) pubmed
- Nicotinamide riboside and nicotinamide mononucleotide facilitate NAD(+) synthesis via enterohepatic circulation. (2025) pubmed
- Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. (2016) pubmed
- Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD(+) Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures. (2019) pubmed
- NAD(+) supplementation reduces neuroinflammation and cell senescence in a transgenic mouse model of Alzheimer's disease via cGAS-STING. (2021) pubmed
- Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults. (2019) pubmed
- NAD(+) Intermediates: The Biology and Therapeutic Potential of NMN and NR. (2018) pubmed